Hampton, Virginia • Velocity Clinical Research
Phone: (757) 520-5111
Scientists are researching an investigational mRNA vaccine in this study.
RSV can cause life-threatening respiratory infections in seniors, immunocompromised people, and infants. RSV infects about 5% to 10% of residents in long-term facilities each year, and can lead to pneumonia. Learn more about this research study of an investigational vaccine intended to prevent RSV.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy